High-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting in mantle cell lymphoma: a 10-year update of the R-HDS regimen
Open Access
- 27 October 2008
- journal article
- letter
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 43 (6), 509-511
- https://doi.org/10.1038/bmt.2008.349
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo–purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma GroupBlood, 2008
- Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study GroupBlood, 2008
- A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphomaBlood, 2008
- Update of the M. D. Anderson Cancer Center Experience with Hyper-CVAD and Rituximab for the Treatment of Mantle Cell and Burkitt-Type LymphomasClinical Lymphoma Myeloma and Leukemia, 2007
- Rituximab Induces Effective Clearance of Minimal Residual Disease in Molecular Relapses of Mantle Cell LymphomaTransplantation and Cellular Therapy, 2006
- Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell LymphomaJournal of Clinical Oncology, 2006
- Phase II Trial of Single-Agent Temsirolimus (CCI-779) for Relapsed Mantle Cell LymphomaJournal of Clinical Oncology, 2005
- Immunochemotherapy With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Significantly Improves Response and Time to Treatment Failure, But Not Long-Term Outcome in Patients With Previously Untreated Mantle Cell Lymphoma: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG)Journal of Clinical Oncology, 2005
- Rituximab: enhancing stem cell transplantation in mantle cell lymphomaBone Marrow Transplantation, 2002
- High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.Journal of Clinical Oncology, 1998